Pharmaceutical multinational corporations (MNCs) and their exit from low and middle income countries (LMICs): analysing the causes and consequences
Muhammad Akhtar Abbas Khan · 2024
Read Pharmaceutical multinational corporations (MNCs) and their exit from low and middle income countries (LMICs): analysing the causes and consequences by Muhammad Akhtar Abbas Khan (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11578402.txt.
Description
Muhammad Akhtar Abbas Khan wrote this 2024 analysis of why big foreign drug firms are leaving poorer lands, with Pakistan as the lens. Such firms brought new drugs and know-how, yet plant sales to local buyers have fanned debate. Local firms now hold about three quarters of the Pakistani market, up from less, while the giants' share has slid to about a quarter.
Khan names the squeeze: stiff local rivalry, mergers that stall plant growth, and joint ventures that feed the locals. Price freedom for non-essential drugs may lure the giants back, he notes. Holding ground will take fresh molecules and modern plants. The piece weighs what exits cost a health system in new treatments and jobs.
Catalog record
| CREATOR | Muhammad Akhtar Abbas Khan |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 19 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |